speb/financial-data huggingface dataset:
CLDI income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 330000.00
CLDI balance_sheet (annual, 2025-12-31) — Working Capital: 2321000.00
CLDI balance_sheet (quarterly, 2025-12-31) — Working Capital: 2321000.00
CLDI income_statement (quarterly, 2026-03-31) — +Operating Expense: 4187000.00
CLDI income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
CLDI balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 849000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -1753000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 150685000.00
CLDI income_statement (quarterly, 2026-03-31) — Basic Average Shares: 10308000.00
CLDI income_statement (quarterly, 2026-03-31) — Basic EPS: -0.43
CLDI cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 5819000.00
CLDI cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -5000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 1657000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 6631000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 6631000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Cash Financial: 6631000.00
CLDI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 5159000.00
CLDI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -5000.00
CLDI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -4116000.00
CLDI cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 232000.00
CLDI cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -458000.00
CLDI cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -325000.00
CLDI cash_flow (quarterly, 2026-03-31) — Change In Payable: 232000.00
CLDI cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -226000.00
CLDI cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -66000.00
CLDI cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -617000.00
CLDI cash_flow (quarterly, 2026-03-31) — Changes In Cash: 1038000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Common Stock: 1000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 4935000.00
CLDI cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 5369000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 1432000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Current Assets: 7353000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1504000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1504000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 3836000.00
CLDI cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 426000.00
CLDI cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 426000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 67000.00
CLDI income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 10308000.00
CLDI income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.43
CLDI income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -4417000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 51000.00
CLDI income_statement (quarterly, 2026-03-31) — EBIT: -4066000.00
CLDI income_statement (quarterly, 2026-03-31) — EBITDA: -3640000.00
CLDI cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -7000.00
CLDI cash_flow (quarterly, 2026-03-31) — End Cash Position: 6850000.00
CLDI cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 5159000.00
CLDI cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -4121000.00
CLDI income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 48000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -22000.00
CLDI income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 1600000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Gross PPE: 3853000.00
CLDI cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 4000.00
CLDI income_statement (quarterly, 2026-03-31) — Interest Expense: 38000.00
CLDI income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 38000.00
CLDI cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 101000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Invested Capital: 5535000.00
CLDI cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -5000.00
CLDI cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 5369000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 153000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 600000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 753000.00
CLDI cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -44000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 2511000.00
CLDI income_statement (quarterly, 2026-03-31) — Minority Interests: 0.00
CLDI cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 5369000.00
CLDI income_statement (quarterly, 2026-03-31) — Net Income: -4108000.00
CLDI income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -4417000.00
CLDI income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -4108000.00
CLDI income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -4108000.00
CLDI income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -4108000.00
CLDI cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -4108000.00
CLDI income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -4108000.00
CLDI income_statement (quarterly, 2026-03-31) — Net Interest Income: -38000.00
CLDI cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -44000.00
CLDI cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -44000.00
CLDI income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -38000.00
CLDI cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -171000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Net PPE: 2100000.00
CLDI cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -5000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 4935000.00
CLDI income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -3688000.00
CLDI income_statement (quarterly, 2026-03-31) — Normalized Income: -4136800.00
CLDI cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -4116000.00
CLDI income_statement (quarterly, 2026-03-31) — Operating Income: -4187000.00
CLDI income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
CLDI balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 11786725.00
CLDI balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 238000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -22000.00
CLDI income_statement (quarterly, 2026-03-31) — Other Gand A: 1600000.00
CLDI income_statement (quarterly, 2026-03-31) — Other Income Expense: 121000.00
CLDI cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -48000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 138000.00
CLDI income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 73000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Other Properties: 1342000.00
CLDI income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 309000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Payables: 900000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 2332000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 484000.00
CLDI income_statement (quarterly, 2026-03-31) — Pretax Income: -4104000.00
CLDI cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 5000.00
CLDI cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -5000.00
CLDI income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 426000.00
CLDI cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -44000.00
CLDI income_statement (quarterly, 2026-03-31) — Research And Development: 2587000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -145729000.00
CLDI income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1600000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Share Issued: 11786725.00
CLDI cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 231000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 4935000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 4935000.00
CLDI income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 19200.00
CLDI income_statement (quarterly, 2026-03-31) — Tax Provision: 4000.00
CLDI income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CLDI balance_sheet (quarterly, 2026-03-31) — Total Assets: 9591000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 5535000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Total Debt: 2257000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 4935000.00
CLDI income_statement (quarterly, 2026-03-31) — Total Expenses: 4187000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 4656000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 2238000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 820000.00
CLDI income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -4187000.00
CLDI income_statement (quarterly, 2026-03-31) — Total Unusual Items: 48000.00
CLDI income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 48000.00
CLDI balance_sheet (quarterly, 2026-03-31) — Working Capital: 3517000.00
CLDN.L income_statement (annual, 2022-03-31) — +Operating Expense: 33600000.00
CLDN.L income_statement (annual, 2022-03-31) — +Total Revenue: 625600000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Accounts Payable: 22400000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -2600000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 2700000.00
CLDN.L income_statement (annual, 2022-03-31) — Basic Average Shares: 54502000.00
CLDN.L income_statement (annual, 2022-03-31) — Basic EPS: 11.21
CLDN.L cash_flow (annual, 2022-03-31) — Beginning Cash Position: 14200000.00
CLDN.L cash_flow (annual, 2022-03-31) — Capital Expenditure: -400000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Capital Stock: 2700000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 341100000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Federal Funds Sold: 341100000.00
CLDN.L cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -34600000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Cash Equivalents: 330300000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Cash Financial: 10800000.00
CLDN.L cash_flow (annual, 2022-03-31) — Cash Flowsfromusedin Operating Activities Direct: 36100000.00
CLDN.L cash_flow (annual, 2022-03-31) — Changes In Cash: 326900000.00
CLDN.L cash_flow (annual, 2022-03-31) — Classesof Cash Payments: -20500000.00
CLDN.L cash_flow (annual, 2022-03-31) — Classesof Cash Receiptsfrom Operating Activities: 56600000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Common Stock: 2700000.00
CLDN.L cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -34600000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Common Stock Equity: 2782700000.00
CLDN.L cash_flow (annual, 2022-03-31) — Common Stock Payments: -27500000.00
CLDN.L income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 1200000.00
CLDN.L income_statement (annual, 2022-03-31) — Depreciation Income Statement: 1200000.00
CLDN.L income_statement (annual, 2022-03-31) — Diluted Average Shares: 55489000.00
CLDN.L income_statement (annual, 2022-03-31) — Diluted EPS: 1.10
CLDN.L income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 611200000.00
CLDN.L cash_flow (annual, 2022-03-31) — End Cash Position: 341100000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 2385400000.00
CLDN.L cash_flow (annual, 2022-03-31) — Financing Cash Flow: -84100000.00
CLDN.L cash_flow (annual, 2022-03-31) — Free Cash Flow: 35700000.00
CLDN.L income_statement (annual, 2022-03-31) — Gain On Sale Of Security: 567100000.00
CLDN.L income_statement (annual, 2022-03-31) — General And Administrative Expense: 8300000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Gross PPE: 31800000.00
CLDN.L income_statement (annual, 2022-03-31) — Interest Expense: 2300000.00
CLDN.L income_statement (annual, 2022-03-31) — Interest Income: 1700000.00
CLDN.L cash_flow (annual, 2022-03-31) — Interest Paid Cff: -2600000.00
CLDN.L cash_flow (annual, 2022-03-31) — Investing Cash Flow: 374900000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Investment Properties: 16000000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 2385400000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Investments And Advances: 2385400000.00
CLDN.L cash_flow (annual, 2022-03-31) — Issuance Of Debt: 0.00
CLDN.L cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 0.00
CLDN.L cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -19400000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 0.00
CLDN.L cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: -27500000.00
CLDN.L income_statement (annual, 2022-03-31) — Net Income: 611200000.00
CLDN.L income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 611200000.00
CLDN.L income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 611200000.00
CLDN.L income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 611200000.00
CLDN.L income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 611200000.00
CLDN.L income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 611200000.00
CLDN.L income_statement (annual, 2022-03-31) — Net Interest Income: -600000.00
CLDN.L cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: 375300000.00
CLDN.L cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: -19400000.00
CLDN.L cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -19400000.00
CLDN.L cash_flow (annual, 2022-03-31) — Net Other Financing Charges: 0.00
CLDN.L balance_sheet (annual, 2022-03-31) — Net PPE: 29200000.00
CLDN.L cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -400000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 2782700000.00
CLDN.L income_statement (annual, 2022-03-31) — Normalized Income: 611200000.00
CLDN.L income_statement (annual, 2022-03-31) — Operating Revenue: 625600000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 54663662.00
CLDN.L cash_flow (annual, 2022-03-31) — Other Cash Paymentsfrom Operating Activities: -20400000.00
CLDN.L cash_flow (annual, 2022-03-31) — Other Cash Receiptsfrom Operating Activities: 500000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Other Equity Interest: 400000.00
CLDN.L income_statement (annual, 2022-03-31) — Other Operating Expenses: 400000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Payables: 22500000.00
CLDN.L income_statement (annual, 2022-03-31) — Pretax Income: 592000000.00
CLDN.L cash_flow (annual, 2022-03-31) — Purchase Of Investment: -226900000.00
CLDN.L cash_flow (annual, 2022-03-31) — Purchase Of PPE: -400000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Receivables: 7500000.00
CLDN.L income_statement (annual, 2022-03-31) — Reconciled Depreciation: 1200000.00
CLDN.L cash_flow (annual, 2022-03-31) — Repayment Of Debt: -19400000.00
CLDN.L cash_flow (annual, 2022-03-31) — Repurchase Of Capital Stock: -27500000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Retained Earnings: 263200000.00
CLDN.L cash_flow (annual, 2022-03-31) — Sale Of Investment: 602200000.00
CLDN.L income_statement (annual, 2022-03-31) — Selling General And Administration: 8300000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Share Issued: 54663662.00
CLDN.L balance_sheet (annual, 2022-03-31) — Stockholders Equity: 2782700000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Tangible Book Value: 2782700000.00
CLDN.L income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 0.00
CLDN.L income_statement (annual, 2022-03-31) — Tax Provision: -19200000.00
CLDN.L income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.19
CLDN.L balance_sheet (annual, 2022-03-31) — Taxes Receivable: 8900000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Total Assets: 2814600000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 2782700000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 31900000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Total Tax Payable: 100000.00
CLDN.L income_statement (annual, 2022-03-31) — Total Unusual Items: 3600000.00
CLDN.L income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: 3600000.00
CLDN.L balance_sheet (annual, 2022-03-31) — Treasury Stock: 13300000.00
CLDN.L income_statement (annual, 2023-03-31) — +Operating Expense: 30800000.00
CLDN.L income_statement (annual, 2023-03-31) — +Total Revenue: 180000000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Accounts Payable: 22100000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -3100000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 2700000.00
CLDN.L income_statement (annual, 2023-03-31) — Basic Average Shares: 54288000.00
CLDN.L income_statement (annual, 2023-03-31) — Basic EPS: 2.63
CLDN.L cash_flow (annual, 2023-03-31) — Beginning Cash Position: 341100000.00
CLDN.L cash_flow (annual, 2023-03-31) — Capital Expenditure: -300000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Capital Stock: 2700000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 221600000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Federal Funds Sold: 221600000.00
CLDN.L cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -130500000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Cash Equivalents: 214300000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Cash Financial: 7300000.00
CLDN.L cash_flow (annual, 2023-03-31) — Cash Flowsfromusedin Operating Activities Direct: 27500000.00
CLDN.L cash_flow (annual, 2023-03-31) — Changes In Cash: -119500000.00
CLDN.L cash_flow (annual, 2023-03-31) — Classesof Cash Payments: -25300000.00
CLDN.L cash_flow (annual, 2023-03-31) — Classesof Cash Receiptsfrom Operating Activities: 52800000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Common Stock: 2700000.00
CLDN.L cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -130500000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Common Stock Equity: 2798000000.00
CLDN.L cash_flow (annual, 2023-03-31) — Common Stock Payments: -4000000.00
CLDN.L income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 1100000.00
CLDN.L income_statement (annual, 2023-03-31) — Depreciation Income Statement: 1100000.00
CLDN.L income_statement (annual, 2023-03-31) — Diluted Average Shares: 55169000.00
CLDN.L income_statement (annual, 2023-03-31) — Diluted EPS: 0.26
CLDN.L income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 142900000.00
CLDN.L cash_flow (annual, 2023-03-31) — End Cash Position: 221600000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 2794900000.00
CLDN.L cash_flow (annual, 2023-03-31) — Financing Cash Flow: 129300000.00
CLDN.L cash_flow (annual, 2023-03-31) — Free Cash Flow: 27200000.00
CLDN.L income_statement (annual, 2023-03-31) — Gain On Sale Of Security: 133000000.00
CLDN.L income_statement (annual, 2023-03-31) — General And Administrative Expense: 9500000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Gross PPE: 31000000.00
CLDN.L income_statement (annual, 2023-03-31) — Interest Expense: 2400000.00
CLDN.L income_statement (annual, 2023-03-31) — Interest Income: 6400000.00
CLDN.L cash_flow (annual, 2023-03-31) — Interest Paid Cff: -2200000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Invested Capital: 3064000000.00
CLDN.L cash_flow (annual, 2023-03-31) — Investing Cash Flow: -276300000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Investment Properties: 15100000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 2794900000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Investments And Advances: 2794900000.00
CLDN.L cash_flow (annual, 2023-03-31) — Issuance Of Debt: 266000000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 266000000.00
CLDN.L cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 266000000.00
CLDN.L cash_flow (annual, 2023-03-31) — Long Term Debt Payments: 0.00
CLDN.L balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 0.00
CLDN.L cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: -4000000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Net Debt: 44400000.00
CLDN.L income_statement (annual, 2023-03-31) — Net Income: 142900000.00
CLDN.L income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 142900000.00
CLDN.L income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 142900000.00
CLDN.L income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 142900000.00
CLDN.L income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 142900000.00
CLDN.L income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 142900000.00
CLDN.L income_statement (annual, 2023-03-31) — Net Interest Income: 4000000.00
CLDN.L cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -276000000.00
CLDN.L cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 266000000.00
CLDN.L cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 266000000.00
CLDN.L cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 0.00
CLDN.L balance_sheet (annual, 2023-03-31) — Net PPE: 27900000.00
CLDN.L cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -300000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 2798000000.00
CLDN.L income_statement (annual, 2023-03-31) — Normalized Income: 142900000.00
CLDN.L income_statement (annual, 2023-03-31) — Operating Revenue: 180000000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 54325700.00
CLDN.L cash_flow (annual, 2023-03-31) — Other Cash Paymentsfrom Operating Activities: -25300000.00
CLDN.L cash_flow (annual, 2023-03-31) — Other Cash Receiptsfrom Operating Activities: 2600000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Other Equity Interest: 400000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Payables: 22100000.00
CLDN.L income_statement (annual, 2023-03-31) — Pretax Income: 149200000.00
CLDN.L cash_flow (annual, 2023-03-31) — Purchase Of Investment: -468100000.00
CLDN.L cash_flow (annual, 2023-03-31) — Purchase Of PPE: -300000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Receivables: 6900000.00
CLDN.L income_statement (annual, 2023-03-31) — Reconciled Depreciation: 1100000.00
CLDN.L cash_flow (annual, 2023-03-31) — Repayment Of Debt: 0.00
CLDN.L cash_flow (annual, 2023-03-31) — Repurchase Of Capital Stock: -4000000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Retained Earnings: 247400000.00
CLDN.L cash_flow (annual, 2023-03-31) — Sale Of Investment: 192100000.00
CLDN.L income_statement (annual, 2023-03-31) — Selling General And Administration: 9500000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Share Issued: 54663662.00
CLDN.L balance_sheet (annual, 2023-03-31) — Stockholders Equity: 2798000000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Tangible Book Value: 2798000000.00
CLDN.L income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
CLDN.L income_statement (annual, 2023-03-31) — Tax Provision: 6300000.00
CLDN.L income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.04
CLDN.L balance_sheet (annual, 2023-03-31) — Taxes Receivable: 19300000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Total Assets: 3095400000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Total Capitalization: 3064000000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Total Debt: 266000000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 2798000000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 297400000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Total Tax Payable: 0.00
CLDN.L income_statement (annual, 2023-03-31) — Total Unusual Items: -1400000.00
CLDN.L income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -1400000.00
CLDN.L balance_sheet (annual, 2023-03-31) — Treasury Shares Number: 337962.00
CLDN.L balance_sheet (annual, 2023-03-31) — Treasury Stock: 10600000.00
CLDN.L income_statement (annual, 2024-03-31) — +Operating Expense: 32400000.00
CLDN.L income_statement (annual, 2024-03-31) — +Total Revenue: 233800000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Accounts Payable: 24400000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -3400000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 2700000.00
CLDN.L income_statement (annual, 2024-03-31) — Basic Average Shares: 54393000.00
CLDN.L income_statement (annual, 2024-03-31) — Basic EPS: 3.75
CLDN.L cash_flow (annual, 2024-03-31) — Beginning Cash Position: 221600000.00
CLDN.L cash_flow (annual, 2024-03-31) — Capital Expenditure: -500000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Capital Stock: 2700000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 227400000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Federal Funds Sold: 227400000.00
CLDN.L cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -37000000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Cash Equivalents: 223500000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Cash Financial: 3900000.00
CLDN.L cash_flow (annual, 2024-03-31) — Cash Flowsfromusedin Operating Activities Direct: 59900000.00
CLDN.L cash_flow (annual, 2024-03-31) — Changes In Cash: 6800000.00
CLDN.L cash_flow (annual, 2024-03-31) — Classesof Cash Payments: -24300000.00
CLDN.L cash_flow (annual, 2024-03-31) — Classesof Cash Receiptsfrom Operating Activities: 84200000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Common Stock: 2700000.00
CLDN.L cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -37000000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Common Stock Equity: 2965300000.00
CLDN.L cash_flow (annual, 2024-03-31) — Common Stock Payments: -5300000.00
CLDN.L income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 1100000.00
CLDN.L income_statement (annual, 2024-03-31) — Depreciation Income Statement: 1100000.00
CLDN.L income_statement (annual, 2024-03-31) — Diluted Average Shares: 55237000.00
CLDN.L income_statement (annual, 2024-03-31) — Diluted EPS: 3.69
CLDN.L income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 203800000.00
CLDN.L cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: -1000000.00
CLDN.L cash_flow (annual, 2024-03-31) — End Cash Position: 227400000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 2695400000.00
CLDN.L cash_flow (annual, 2024-03-31) — Financing Cash Flow: -311500000.00
CLDN.L cash_flow (annual, 2024-03-31) — Free Cash Flow: 59400000.00
CLDN.L income_statement (annual, 2024-03-31) — Gain On Sale Of Security: 174400000.00
CLDN.L income_statement (annual, 2024-03-31) — General And Administrative Expense: 10100000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Gross PPE: 28600000.00
CLDN.L income_statement (annual, 2024-03-31) — Interest Expense: 10600000.00
CLDN.L income_statement (annual, 2024-03-31) — Interest Income: 5700000.00
CLDN.L cash_flow (annual, 2024-03-31) — Interest Paid Cff: -10400000.00
CLDN.L cash_flow (annual, 2024-03-31) — Investing Cash Flow: 258400000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Investment Properties: 13300000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 2695400000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Investments And Advances: 2695400000.00
CLDN.L cash_flow (annual, 2024-03-31) — Issuance Of Debt: 70000000.00
CLDN.L cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 70000000.00
CLDN.L cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -328800000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 0.00
CLDN.L cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: -5300000.00
CLDN.L income_statement (annual, 2024-03-31) — Net Income: 203800000.00
CLDN.L income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 203800000.00
CLDN.L income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 203800000.00
CLDN.L income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 203800000.00
CLDN.L income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 203800000.00
CLDN.L income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 203800000.00
CLDN.L income_statement (annual, 2024-03-31) — Net Interest Income: -4900000.00
CLDN.L cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 258900000.00
CLDN.L cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -258800000.00
CLDN.L cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -258800000.00
CLDN.L cash_flow (annual, 2024-03-31) — Net Other Financing Charges: 0.00
CLDN.L balance_sheet (annual, 2024-03-31) — Net PPE: 25200000.00
CLDN.L cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -500000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 2965300000.00
CLDN.L income_statement (annual, 2024-03-31) — Normalized Income: 203800000.00
CLDN.L income_statement (annual, 2024-03-31) — Operating Revenue: 233800000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 54388093.00
CLDN.L cash_flow (annual, 2024-03-31) — Other Cash Paymentsfrom Operating Activities: -23500000.00
CLDN.L cash_flow (annual, 2024-03-31) — Other Cash Receiptsfrom Operating Activities: 1500000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Other Equity Interest: 400000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Payables: 24400000.00
CLDN.L income_statement (annual, 2024-03-31) — Pretax Income: 201400000.00
CLDN.L cash_flow (annual, 2024-03-31) — Purchase Of Investment: -340800000.00
CLDN.L cash_flow (annual, 2024-03-31) — Purchase Of PPE: -500000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Receivables: 7300000.00
CLDN.L income_statement (annual, 2024-03-31) — Reconciled Depreciation: 1100000.00
CLDN.L cash_flow (annual, 2024-03-31) — Repayment Of Debt: -328800000.00
CLDN.L cash_flow (annual, 2024-03-31) — Repurchase Of Capital Stock: -5300000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Retained Earnings: 250200000.00
CLDN.L cash_flow (annual, 2024-03-31) — Sale Of Investment: 599700000.00
CLDN.L income_statement (annual, 2024-03-31) — Selling General And Administration: 10100000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Share Issued: 54611759.00
CLDN.L balance_sheet (annual, 2024-03-31) — Stockholders Equity: 2965300000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Tangible Book Value: 2965300000.00
CLDN.L income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
CLDN.L income_statement (annual, 2024-03-31) — Tax Provision: -2400000.00
CLDN.L income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.25
CLDN.L balance_sheet (annual, 2024-03-31) — Taxes Receivable: 1700000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Total Assets: 2998900000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 2965300000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 33600000.00
CLDN.L income_statement (annual, 2024-03-31) — Total Unusual Items: -3900000.00
CLDN.L income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -3900000.00
CLDN.L balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 223666.00
CLDN.L balance_sheet (annual, 2024-03-31) — Treasury Stock: 7300000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 25800000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Additional Paid In Capital: 2700000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Capital Stock: 3100000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 134600000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Federal Funds Sold: 134600000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Common Stock: 3100000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 2917700000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 2754700000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Investment Properties: 13300000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 2754700000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 2754700000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Net PPE: 26500000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 2917700000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 537312820.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Payables: 25800000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Receivables: 8100000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Retained Earnings: 240100000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Share Issued: 538647960.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 2917700000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 2917700000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 4500000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Total Assets: 2950200000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 2917700000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 32500000.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Treasury Shares Number: 1335140.00
CLDN.L balance_sheet (quarterly, 2024-09-30) — Treasury Stock: 4500000.00
CLDN.L income_statement (annual, 2025-03-31) — +Operating Expense: 37300000.00
CLDN.L income_statement (annual, 2025-03-31) — +Total Revenue: 104100000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Accounts Payable: 16400000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 16400000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -3900000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -3900000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 2800000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 2800000.00
CLDN.L income_statement (annual, 2025-03-31) — Basic Average Shares: 537210000.00
CLDN.L income_statement (annual, 2025-03-31) — Basic EPS: 0.12
CLDN.L cash_flow (annual, 2025-03-31) — Beginning Cash Position: 227400000.00
CLDN.L cash_flow (annual, 2025-03-31) — Capital Expenditure: -1800000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Capital Stock: 2600000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2600000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 151300000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 151300000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 151300000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 151300000.00
CLDN.L cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -38400000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Cash Equivalents: 141500000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 141500000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Cash Financial: 9800000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Cash Financial: 9800000.00
CLDN.L cash_flow (annual, 2025-03-31) — Cash Flowsfromusedin Operating Activities Direct: 17900000.00
CLDN.L cash_flow (annual, 2025-03-31) — Changes In Cash: -75200000.00
CLDN.L cash_flow (annual, 2025-03-31) — Classesof Cash Payments: -32500000.00
CLDN.L cash_flow (annual, 2025-03-31) — Classesof Cash Receiptsfrom Operating Activities: 50400000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Common Stock: 2600000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Common Stock: 2600000.00
CLDN.L cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -38400000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Common Stock Equity: 2931600000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 2931600000.00
CLDN.L cash_flow (annual, 2025-03-31) — Common Stock Payments: -67700000.00
CLDN.L income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 1200000.00
CLDN.L income_statement (annual, 2025-03-31) — Depreciation Income Statement: 1200000.00
CLDN.L income_statement (annual, 2025-03-31) — Diluted Average Shares: 545140000.00
CLDN.L income_statement (annual, 2025-03-31) — Diluted EPS: 0.12
CLDN.L income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 66100000.00
CLDN.L cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: -900000.00
CLDN.L cash_flow (annual, 2025-03-31) — End Cash Position: 151300000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 2743600000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 2743600000.00
CLDN.L cash_flow (annual, 2025-03-31) — Financing Cash Flow: -109800000.00
CLDN.L cash_flow (annual, 2025-03-31) — Free Cash Flow: 16100000.00
CLDN.L income_statement (annual, 2025-03-31) — General And Administrative Expense: 12000000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Gross PPE: 29200000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Gross PPE: 29200000.00
CLDN.L income_statement (annual, 2025-03-31) — Interest Expense: 3500000.00
CLDN.L income_statement (annual, 2025-03-31) — Interest Income: 12900000.00
CLDN.L cash_flow (annual, 2025-03-31) — Interest Paid Cff: -3700000.00
CLDN.L cash_flow (annual, 2025-03-31) — Investing Cash Flow: 16700000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Investment Properties: 12600000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Investment Properties: 12600000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 2743600000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 2743600000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Investments And Advances: 2743600000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 2743600000.00
CLDN.L cash_flow (annual, 2025-03-31) — Issuance Of Debt: 0.00
CLDN.L cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 0.00
CLDN.L cash_flow (annual, 2025-03-31) — Long Term Debt Payments: 0.00
CLDN.L balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 0.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 0.00
CLDN.L cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: -67700000.00
CLDN.L income_statement (annual, 2025-03-31) — Net Income: 66100000.00
CLDN.L income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 66100000.00
CLDN.L income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 66100000.00
CLDN.L income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 66100000.00
CLDN.L income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 66100000.00
CLDN.L income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 66100000.00
CLDN.L income_statement (annual, 2025-03-31) — Net Interest Income: 9400000.00
CLDN.L cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 18500000.00
CLDN.L cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
CLDN.L cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 0.00
CLDN.L cash_flow (annual, 2025-03-31) — Net Other Financing Charges: 0.00
CLDN.L balance_sheet (annual, 2025-03-31) — Net PPE: 25300000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Net PPE: 25300000.00
CLDN.L cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -1800000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 2931600000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 2931600000.00
CLDN.L income_statement (annual, 2025-03-31) — Normalized Income: 66100000.00
CLDN.L income_statement (annual, 2025-03-31) — Operating Revenue: 104100000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 52749673.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 527496730.00
CLDN.L cash_flow (annual, 2025-03-31) — Other Cash Paymentsfrom Operating Activities: -29700000.00
CLDN.L cash_flow (annual, 2025-03-31) — Other Cash Receiptsfrom Operating Activities: 1300000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Other Equity Interest: 400000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 400000.00
CLDN.L income_statement (annual, 2025-03-31) — Other Operating Expenses: 2400000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Payables: 16400000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Payables: 16400000.00
CLDN.L income_statement (annual, 2025-03-31) — Pretax Income: 66800000.00
CLDN.L cash_flow (annual, 2025-03-31) — Purchase Of Investment: -318900000.00
CLDN.L cash_flow (annual, 2025-03-31) — Purchase Of PPE: -1800000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Receivables: 10300000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Receivables: 10300000.00
CLDN.L income_statement (annual, 2025-03-31) — Reconciled Depreciation: 1200000.00
CLDN.L cash_flow (annual, 2025-03-31) — Repayment Of Debt: 0.00
CLDN.L cash_flow (annual, 2025-03-31) — Repurchase Of Capital Stock: -67700000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Retained Earnings: 240400000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 240400000.00
CLDN.L cash_flow (annual, 2025-03-31) — Sale Of Investment: 337400000.00
CLDN.L income_statement (annual, 2025-03-31) — Selling General And Administration: 12000000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Share Issued: 52882698.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Share Issued: 528826980.00
CLDN.L balance_sheet (annual, 2025-03-31) — Stockholders Equity: 2931600000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 2931600000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Tangible Book Value: 2931600000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 2931600000.00
CLDN.L income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CLDN.L income_statement (annual, 2025-03-31) — Tax Provision: 700000.00
CLDN.L income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.01
CLDN.L balance_sheet (annual, 2025-03-31) — Taxes Receivable: 4200000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 4200000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Total Assets: 2958000000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Total Assets: 2958000000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 2931600000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 2931600000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 26400000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 26400000.00
CLDN.L balance_sheet (annual, 2025-03-31) — Treasury Shares Number: 133025.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 1330250.00
CLDN.L balance_sheet (annual, 2025-03-31) — Treasury Stock: 4500000.00
CLDN.L balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 4500000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 5400000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 2800000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Capital Stock: 3000000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 105400000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 105400000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Common Stock: 3000000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 3011700000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 2598300000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Investment Properties: 13700000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 2598300000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 2598300000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Net PPE: 24300000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 3011700000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 523533659.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Payables: 5400000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Receivables: 8500000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 246700000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Share Issued: 525108917.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 3011700000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 3011700000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 5000000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Total Assets: 3024900000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 3011700000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 13200000.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 1575258.00
CLDN.L balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 5700000.00
CLDN.L income_statement (annual, 2026-03-31) — +Operating Expense: 32400000.00
CLDN.L income_statement (annual, 2026-03-31) — +Total Revenue: 160500000.00
CLDN.L balance_sheet (annual, 2026-03-31) — Accounts Payable: 5800000.00
CLDN.L balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 5800000.00
CLDN.L balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -4500000.00
CLDN.L balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -4500000.00
CLDN.L balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 2800000.00
CLDN.L balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 2800000.00
CLDN.L income_statement (annual, 2026-03-31) — Basic Average Shares: 522542000.00
CLDN.L income_statement (annual, 2026-03-31) — Basic EPS: 0.26
CLDN.L cash_flow (annual, 2026-03-31) — Beginning Cash Position: 151300000.00
CLDN.L cash_flow (annual, 2026-03-31) — Capital Expenditure: -200000.00
CLDN.L balance_sheet (annual, 2026-03-31) — Capital Stock: 2600000.00
CLDN.L balance_sheet (quarterly, 2026-03-31) — Capital Stock: 2600000.00
CLDN.L balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 90000000.00
CLDN.L balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 90000000.00
CLDN.L balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 90000000.00